Bender Robert & Associates Abb Vie Inc. Transaction History

Bender Robert & Associates

$471 Million
Q3 2024

A detailed history of Bender Robert & Associates transactions in Abb Vie Inc. stock. As of the latest transaction made, Bender Robert & Associates holds 4,329 shares of ABBV stock, worth $760,085. This represents 0.18% of its overall portfolio holdings.

Number of Shares

4,329

Previous 7,466 42.02%

Holding current value

$760,085

Previous $1.28 Million 33.28%

% of portfolio

0.18%

Previous 0.28%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$163.84 - $199.33 $709,263 - $862,899	4,329 New	4,329 $854,000
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $101,166 - $115,269	-633 Reduced 6.91%	8,524 $1.55 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $512,835 - $577,573	-3,727 Reduced 28.93%	9,157 $1.42 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $97,654 - $113,049	-731 Reduced 5.37%	12,884 $1.92 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $2.3 Million - $2.86 Million	-17,349 Reduced 56.03%	13,615 $1.83 Million
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $21,836 - $25,147	-151 Reduced 0.49%	30,964 $4.93 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $162,652 - $195,063	-1,176 Reduced 3.64%	31,115 $5.03 Million
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $10,736 - $12,314	-80 Reduced 0.25%	32,291 $4.33 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $109,958 - $139,793	-799 Reduced 2.41%	32,371 $4.96 Million
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $133,299 - $165,387	-1,010 Reduced 2.95%	33,170 $5.38 Million
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $35,324 - $40,098	-332 Reduced 0.96%	34,180 $3.69 Million
Q2 2021 Jul 16, 2021	SELL	$105.21 - $117.21 $15,781 - $17,581	-150 Reduced 0.43%	34,512 $3.89 Million
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $511 - $563	-5 Reduced 0.01%	34,662 $3.75 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $101,819 - $137,467	1,265 Added 3.79%	34,667 $3.72 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $163,658 - $192,081	-1,905 Reduced 5.4%	33,402 $2.93 Million
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $131,185 - $175,545	-1,788 Reduced 4.82%	35,307 $3.47 Million
Q1 2020 Apr 21, 2020	SELL	$64.5 - $97.79 $113,842 - $172,599	-1,765 Reduced 4.54%	37,095 $2.83 Million
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $175,420 - $219,488	-2,432 Reduced 5.89%	38,860 $3.44 Million
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $111,096 - $133,570	-1,764 Reduced 4.1%	41,292 $3.13 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $271,275 - $346,753	-4,129 Reduced 8.75%	43,056 $2.92 Million
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $665,795 - $783,608	-8,631 Reduced 15.46%	47,185 $3.8 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $68,040 - $83,912	-874 Reduced 1.54%	55,816 $5.15 Million
Q3 2018 Oct 17, 2018	BUY	$88.91 - $98.84 $1,333 - $1,482	15 Added 0.03%	56,690 $5.36 Million
Q2 2018 Jul 27, 2018	BUY	$89.78 - $106.23 $36,450 - $43,129	406 Added 0.72%	56,675 $5.25 Million
Q1 2018 Apr 27, 2018	SELL	$92.01 - $123.21 $161,385 - $216,110	-1,754 Reduced 3.02%	56,269 $5.33 Million
Q4 2017 Jan 19, 2018	SELL	$89.56 - $98.21 $41,914 - $45,962	-468 Reduced 0.8%	58,023 $5.61 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $4.09 Million - $5.22 Million	58,491	58,491 $5.2 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.

Account

Bender Robert & Associates Abb Vie Inc. Transaction History